CliffBio
small molecule

LEVALBUTEROL HYDROCHLORIDE

LEVALBUTEROL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyMYLAN SPECIALTY LP

Drug detail

Brand nameLEVALBUTEROL HYDROCHLORIDE
Active ingredientLEVALBUTEROL HYDROCHLORIDE
StrengthEQ 0.25% BASE
Dosage formSOLUTION
RouteINHALATION
ModalitySmall molecule
FDA approvalMarch 2009
Marketing statusRX

More from MYLAN SPECIALTY LP

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

LEVALBUTEROL HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio